Navigating New Regulatory Seas: Biopharma’s Critical Shift in Biologic Drug Production and Distribution for Rare Diseases
The biopharmaceutical industry is at a pivotal moment, particularly those involved in developing drugs...
read DetailsRegenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell injections; immunotherapy, and tissue engineering. Existing supply chains were never intended to effectively manage an elevated risk profile for a drug that targets a single patient.
Learn how the cold chain validation landscape for regenerative medicines is rapidly changing because:
The biopharmaceutical industry is at a pivotal moment, particularly those involved in developing drugs...
read DetailsThe biopharmaceutical industry faces a myriad of complex challenges in the delivery of life-saving...
read DetailsReliable cold chain management is more critical than ever in today’s fast-paced and interconnected...
read Details